Skip to main navigation Skip to search Skip to main content

Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life

  • Debbie S. Gipson
  • , Howard Trachtman
  • , Frederick J. Kaskel
  • , Milena K. Radeva
  • , Jennifer Gassman
  • , Tom H. Greene
  • , Marva M. Moxey-Mims
  • , Ronald J. Hogg
  • , Sandra L. Watkins
  • , Richard N. Fine
  • , John P. Middleton
  • , V. M. Vehaskari
  • , Susan L. Hogan
  • , Suzzane Vento
  • , Patti A. Flynn
  • , Leslie M. Powell
  • , June L. McMahan
  • , Norman Siegel
  • , Aaron L. Friedman

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science